scholarly journals Comment on “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”

2019 ◽  
Vol 270 (2) ◽  
pp. e48-e50 ◽  
Author(s):  
Zachary R. McCaw ◽  
Lu Tian ◽  
Dae Hyun Kim ◽  
Lee-Jen Wei
Sign in / Sign up

Export Citation Format

Share Document